Orthopediatrics (KIDS) Operating Income Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | Orthopediatrics | 394.83 Mn | 346.02 Mn | 43.39 Mn | 24.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.10% |
| Dec 31, 2025 | 41.86% |
| Sep 30, 2025 | -69.39% |
| Jun 30, 2025 | -88.09% |
| Mar 31, 2025 | -12.94% |
| Dec 31, 2024 | -74.25% |
| Sep 30, 2024 | -23.47% |
| Jun 30, 2024 | -1.43% |
| Mar 31, 2024 | -13.18% |
| Dec 31, 2023 | 2.92% |
| Sep 30, 2023 | 35.24% |
| Jun 30, 2023 | -49.24% |
| Mar 31, 2023 | -34.53% |
| Dec 31, 2022 | -49.42% |
| Sep 30, 2022 | -91.03% |
| Jun 30, 2022 | -31.52% |
| Mar 31, 2022 | -6.91% |
| Dec 31, 2021 | 56.36% |
| Sep 30, 2021 | -45.88% |
| Jun 30, 2021 | 59.44% |
| Mar 31, 2021 | -32.82% |
| Dec 31, 2020 | -320.42% |
| Sep 30, 2020 | -62.31% |
| Jun 30, 2020 | -292.01% |
| Mar 31, 2020 | -65.51% |
| Dec 31, 2019 | -62.43% |
| Sep 30, 2019 | -31.31% |
| Jun 30, 2019 | 15.57% |
| Mar 31, 2019 | 38.18% |
| Dec 31, 2018 | 55.61% |
| Sep 30, 2018 | -55.44% |
| Jun 30, 2018 | -213.15% |
| Mar 31, 2018 | -425.09% |
| Dec 31, 2017 | -29.27% |
| Sep 30, 2017 | -43.89% |